NanoVision Diagnostics
Kittanning, Pennsylvania, United States · Founded 2013
About NanoVision Diagnostics
NanoVision Diagnostics is commercializing a novel electro-optical cancer diagnostic system. The company develops an optical biomarker intended to offer cancer detection services that conduct an optical analysis of a standard biopsy slide to detect molecular changes in nuclear structure not detectable by pathology that enables medical practitioners to detect and treat cancer in the early stages.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Seed (Jan 2014)
- Website: http://nanovisiondiagnostics.com
- Phone: +1 (724)719-9707
Industries & Categories
Biotechnology, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nanovision-diagnostics-2595687 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.